VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 54 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $41,189 | +23.1% | 5,650 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $33,448 | +0.2% | 5,650 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $33,392 | +76.4% | 5,650 | +16.1% | 0.00% | 0.0% |
| Q3 2023 | $18,928 | -14.3% | 4,866 | +27.1% | 0.00% | 0.0% |
| Q2 2023 | $22,082 | -11.2% | 3,827 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,876 | +226045.5% | 3,827 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11 | -99.8% | 3,827 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -77.4% | 3,827 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $31,000 | -11.4% | 3,827 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -27.1% | 3,828 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $48,000 | +20.0% | 3,828 | +8.5% | 0.00% | 0.0% |
| Q2 2021 | $40,000 | -24.5% | 3,528 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $53,000 | – | 3,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 62,882 | $512,000 | 1.42% |
| Diag Capital Management, LP | 114,947 | $937,000 | 1.07% |
| Perceptive Advisors | 3,410,412 | $27,794,000 | 1.06% |
| Fosun International Ltd | 794,279 | $6,473,000 | 0.39% |
| Orbimed Advisors | 1,479,733 | $12,060,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 63,916 | $521,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 97,000 | $791,000 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 327,420 | $2,668,000 | 0.05% |
| Capital Investment Advisory Services, LLC | 12,400 | $101,000 | 0.04% |
| CONNING INC. | 129,013 | $1,051,000 | 0.04% |